Stryker to Attend the 2024 Wells Fargo Healthcare Conference
Stryker to Attend the 2024 Wells Fargo Healthcare Conference
Portage, Michigan — Stryker (NYSE: SYK) is set to participate in the upcoming 2024 Wells Fargo Healthcare Conference, taking place on September 5 at the Encore Boston Harbor. This participation underscores the company's commitment to dialogue and knowledge sharing within the healthcare sector.
Company Representatives
During this event, Spencer Stiles, the Group President of Orthopaedics and Spine, along with Jason Beach, the Vice President of Finance and Investor Relations, will represent Stryker. Their session is scheduled for 3:00 PM Eastern Time, where they will discuss Stryker's latest innovations and strategies in the context of medical technology advancements.
Webcast Information
A simultaneous webcast will be available for those unable to attend the conference in person. This webcast will not only allow participants to view the presentation live but will also be archived on Stryker’s website for subsequent access. Details about the webcast and the presentation can be found directly on Stryker's official platform.
About Stryker
Stryker is a global leader in medical technology, dedicated to enhancing healthcare outcomes alongside its global customer base. The company pioneers innovative products and services across various sectors, including MedSurg, Neurotechnology, Orthopaedics, and Spine, contributing significantly to the healthcare ecosystem. Remarkably, Stryker positively impacts more than 150 million patients each year, demonstrating its far-reaching influence in the healthcare industry.
Company Contacts
For investor inquiries, interested parties can reach out to:
Jason Beach, Vice President of Finance and Investor Relations at 269-385-2600 or via email at jason.beach@stryker.com.
For media inquiries, please contact:
Yin Becker, Vice President and Chief Corporate Affairs Officer at 269-385-2600 or via email at yin.becker@stryker.com.
Frequently Asked Questions
1. What event is Stryker participating in?
Stryker will participate in the 2024 Wells Fargo Healthcare Conference on September 5.
2. Who will represent Stryker at the conference?
Spencer Stiles and Jason Beach will represent Stryker during the conference.
3. When is Stryker's session at the conference?
Stryker's session is scheduled for 3:00 PM Eastern Time on September 5.
4. Will there be a webcast available for the presentation?
Yes, a simultaneous webcast will be available, and it will also be archived for later viewing.
5. How can I contact Stryker for investor or media inquiries?
You can contact Jason Beach at 269-385-2600 for investor inquiries and Yin Becker at the same number for media inquiries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Global Citizen Campaign Raises $1 Billion to Combat Poverty
- Intuitive Machines' NASA Contract: A Game Changer for Investors
- Understanding the Shifting Landscape of Freight Market Trends
- Examining the Future of PDD Holdings amidst Regulatory Changes
- The Rise of China's Stock Market: Opportunities Ahead
- MLOVE to Showcase Innovative Rangers Speakers at Global Event
- The Future of Hydrogen Power: Is Plug Power Ready for Growth?
- North Korea's Warning on US Military Aid to Ukraine Raises Concerns
- Nvidia's Journey Since IPO: A Shafts Success Story
- Georgia Power's Swift Response Restores Power After Helene
Recent Articles
- ECD Automotive Design Surges with Remarkable Q2 2024 Results
- Kymera Therapeutics Unveils Major Public Offering Plan
- Aspen University Transitions to HCM1 Payment Method Successfully
- Medallion Financial to Engage with Investors in Upcoming Conference
- Actelis Unveils AI-Driven Cybersecurity SaaS for IoT Networks
- Cocrystal Pharma Set to Present Key Clinical Milestones Soon
- 180 Degree Capital Corp. Announces NAV of $4.50 as of June 2024
- Cardlytics Grants Restricted Stock Units to New Employees
- Financial Institutions Inc. Declares Quarterly Cash Dividend of $0.30
- Adeia Celebrates Key Court Decisions Supporting Licensing Efforts
- AEON Biopharma Engages in Major Global Investor Conference 2024
- Covenant Logistics Group Declares Quarterly Dividend Payment
- Key Features to Look for When Choosing a Conversational AI Company
- NORBIT Increases Share Capital Through Employee Incentives
- PickleJar Partners with Thompson Square for Fan Engagement
- BLAQclouds, Inc. Launches BLAQlp.io And ZEUS Acquisition Update
- Embassy Bancorp, Inc. Reports Financial Results for Mid-2024
- TEPKINLY Secures European Approval for Follicular Lymphoma Treatment
- Strategic Development Agreement for Enhanced Production at Oza Field
- Solvay's Share Buyback Program Updates and Company Overview
- Scorpius Holdings Completes Successful Public Offering of Shares
- Shell plc Announces Share Buy-Back Transaction Details
- XPENG Unveils XOS 5.2 OTA Update, Revamping User Experience
- Artisan Partners Growth Team Announces Portfolio Management Shift
- Security Federal Corporation Expands Stock Repurchase Program
- Voltage Shifts: Impact of Brazil’s Grid Operator on Voltalia
- Volta Finance Limited's Performance and NAV Update for July 2024
- GivBux, Inc. Files SEC Form 10 for OTCQB Reporting Status
- Ethical Web AI Unveils Demonstrable Ethical Web Product
- Rexel's Share Trading Disclosure: August 12 to August 16, 2024
- Monthly Report on Voting Rights and Shares for Marie Brizard
- Global Tech Industries Group Reclaims AI Commerce Stock Assets
- Landsbankinn Completes Successful Covered Bond Auction Results
- DEME Group NV Shares Buyback Program Latest Update
- Crossject Appoints Tony Tipton as U.S. COO for ZEPIZURE Launch
- Share Purchase Update for Cargotec Corporation in August 2024
- Technip Energies Share Buyback Report: August 2024 Analysis
- ProPhase Labs Set to Participate in Virtual Investor Summit
- Emerita Resources Secures $6 Million in First Credit Tranche
- IZEA Flex Recognized as Top Influencer Marketing Platform 2024
- AYR Cannabis Expands Retail Presence with New Manchester Store
- Davidson Kempner Capital Management Updates on International Paper
- Davidson Kempner Capital Management LP's Public Disclosure Report
- Resolutions From Vilniaus Baldai AB Shareholders Meeting
- MJ Sully Elevated to Senior Managing Director at Peapack Private
- OSB Group PLC's Recent Shareholding Update and Company Overview
- Anthony Germinaro Joins PetVivo Holdings as Business Manager
- SKYX Partners with EGLO for Lighting Innovations Worldwide
- Ainos Introduces AI Nose Technology Enhancing Factory Safety
- Riksbank Certificates Buyback Overview and Details